NCCM
MDCO

Nine Chapters Capital Management’s Medicines Co MDCO Stock Holding History

Nine Chapters Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-31,200
Closed -$863K – 1215
2014
Q4 		$863K Buy
+31,200
New +$773K 0.07% 375
2013
Q3 		– Sell
-20,400
Closed -$628K – 963
2013
Q2 		$628K Buy
+20,400
New +$682K 0.11% 282

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Nine Chapters Capital Management's MDCO Position: Q1 2015 in Review

Nine Chapters Capital Management sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 31,200 shares — an estimated $863K sold.

Nine Chapters Capital Management first reported a position in MDCO in Q2 2013 and held it in 2 quarters. The position peaked at $863K in Q4 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • Nine Chapters Capital Management reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 31,200 Medicines Co shares in Q1 2015, an estimated $863K.
  • Nine Chapters Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 2 quarters.
  • Nine Chapters Capital Management's Medicines Co position peaked at $863K in Q4 2014.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on Nine Chapters Capital Management's 13F filing for Q1 2015, filed 15 May 2015.